BAGANBAZAR GRAPHEXPLORE · ANALYZE · GROW
Theme
LiveDesk
World/Source-attributed reporting

Eli Lilly easily tops quarterly estimates, raises outlook as Zepbound and Mounjaro sales surge

Eli Lilly now expects 2026 revenue to come in between $85 billion and $87 billion, up from previous guidance of $82 billion to $85 billion.

Eli Lilly now expects 2026 revenue to come in between $85 billion and $87 billion, up from previous guidance of $82 billion to $85 billion.
ORIGINAL SOURCE

Consumer News and Business Channel

This report is indexed by BAGANBAZAR GRAPH with its original publisher named and linked for readers.

Read at original outlet ↗